Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

1.610 +0.090 (+5.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atai Life Sciences N.V.

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
26 27 Next >
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
From atai Life Sciences
Via GlobeNewswire
Allied, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60 
Via Benzinga
atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day
From atai Life Sciences
Via GlobeNewswire
Cybin, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58 
Via Benzinga
September Cannabis Category Performances Ranged From -6.3% To -39.0%
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September... 
Via Talk Markets
Major Psychedelic Stocks Continued To Decline In September
There are 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index. Most - but interestingly not all - were down for the week and/or the month. 
Via Talk Markets
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49 
Via Benzinga
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
Amended Autopsy Confirms Elijah McClain Died From Ketamine Injected By Paramedics Called By Cops 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44 
Via Benzinga
Psychedelic Stock Gainers And Losers From September 28, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16 
Via Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10 
Via Benzinga
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
Atai Life Sciences' (NASDAQ: ATAI) wholly-owned subsidiary EmpathBio has received Medsafe central regulatory and the Health and Disability Ethics Committees (HDEC) approvals to begin participant... 
Via Benzinga
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13 
Via Benzinga
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From September 22, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10 
Via Benzinga
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... 
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From September 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 
Via Benzinga
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62 
Via Benzinga
Psychedelic Stock Gainers And Losers From September 19, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65 
Via Benzinga
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently. 
Via Talk Markets
8 Largest Psychedelic Stocks Continued Their Decline Last Week
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks. 
Via Talk Markets
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81 
Via Benzinga
Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here
The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions... 
Via Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00 
Via Benzinga
8 Largest Psychedelic Stocks Dropped Almost 12% This Week
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From September 9, 2022
GAINERS: Allied (OTC:ALID) shares closed up 21.78% at $0.52 
Via Benzinga
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27 
Via Benzinga
Psychedelic Stock Gainers And Losers From September 7, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.